Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in MEDP — Medpace Holdings, Inc.

CIK 1115418 BOSTON, MA
Back to MEDP Full portfolio

Position in MEDP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$33,654,385
+$3,095,094 QoQ
Shares Held
63,548
-0.1% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#59
of 693 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 51% Shared 0% None 49%

Common Shares in MEDP Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,233,577,400 across 30 Diagnostics & Research names. MEDP ranks #13 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 593,946 $297,780,766
2 DHR
Danaher Corp /De/
 995,923 $189,703,413
3 ILMN
Illumina, Inc.
 560,716 $98,590,694
4 IDXX
Idexx Laboratories Inc /De
 169,208 $89,077,859
5 A
Agilent Technologies, Inc.
 500,807 $66,522,193
6 IQV
Iqvia Holdings Inc.
 332,138 $64,175,704
7 WAT
Waters Corp /De/
 168,771 $63,295,875
8 DGX
Quest Diagnostics Inc
 267,727 $56,744,737

All Filings in MEDP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,654,385 63,548
2026-03-31 $30,559,291 63,640
2025-12-31 $34,808,258 61,975
2025-09-30 $32,691,321 63,582
2025-06-30 $21,176,448 67,471
2025-03-31 $22,000,750 72,207
2024-12-31 $24,359,103 73,320
2024-09-30 $24,280,278 72,739
2024-06-30 $28,829,500 70,000
2024-03-31 $27,463,609 67,954
2023-12-31 $21,729,605 70,889
2023-09-30 $17,626,821 72,799
2023-06-30 $18,140,760 75,533
2023-03-31 $15,245,401 81,071
2022-12-31 $17,336,691 81,619
2022-09-30 $12,671,831 80,625
2022-06-30 $12,165,925 81,285
2022-03-31 $12,883,530 78,755
2021-12-31 $16,742,609 76,928
2021-09-30 $14,467,048 76,432
2021-06-30 $13,150,986 74,455
2021-03-31 $12,246,168 74,649
2020-12-31 $10,761,134 77,307
2020-09-30 $8,527,977 76,313
2020-06-30 $7,766,797 83,496
2020-03-31 $6,485,471 88,382